NCT06147232View on ClinicalTrials.gov

Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
NephropathyDiabetic NephropathiesDiabetes Mellitus, Type 1AlbuminuriaDiabetic Complications RenalDiabetic Complications CardiovascularHypoxia
Interventions
DRUG

Sotagliflozin

Sodium-glucose-co-transporter 1 and 2 inhibitor

DRUG

Placebo

Placebo tablet

Trial Locations (2)

2730

Steno Diabetes Center Copenhagen, Herlev

Unknown

Guy's and St Thomas NHS Trust, London

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

King's College London

OTHER

collaborator

Glostrup University Hospital, Copenhagen

OTHER

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER